Psychologists and other providers who treat Medicare patients can expect to see a drop in payment for a significant number of health care services in 2021, but not diagnostic evaluations or psychotherapy.
On December 1, 2020, the Centers for Medicare and Medicaid Services (CMS) released the final rule on the 2021 Medicare physician fee schedule revealing that the most hotly contested issue—reducing payments to all providers to offset increases for office and outpatient evaluation and management (E/M) services—is being adopted.
Despite APA and many other specialty societies advocating for CMS to work with Congress to waive the budget neutrality requirement that forced the offset, the agency will reduce the conversion factor (CF)—a multiplier used to determine practitioners’ Medicare payments—by 10.2% to $32.41 in 2021.
Although the final rule applies only to Medicare, private insurance carriers often use Medicare fees as a benchmark and could adjust their rates accordingly. APA will now focus its advocacy efforts on lobbying Congress to take action to prevent this projected loss in revenue.
The bright spot in 2021 is that CMS will increase the work values for stand-alone psychotherapy services to maintain relativity with outpatient E/M services. The new value for the 90791 diagnostic evaluation is considerably higher at 15.7%, and values for the 30-, 45-, and 60-minute psychotherapy services will negate the conversion factor reduction.
The agency did not adopt APA’s request to adjust the work values for the health behavior assessment and intervention (HBAI) services and psychological and neuropsychological testing services. The agency’s rationale was that HBAI and testing are fundamentally different from the work performed under E/M codes—i.e. they do not have an obligation to require relativity with the new E/M code values. This means that psychologists providing HBAI services and psychological and neuropsychological testing services will unfortunately see decreases in reimbursement.


